Cardiovascular Assessment of Pediatric Cancer Survivors

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

June 15, 2023

Study Completion Date

June 22, 2023

Conditions
Left Ventricular DysfunctionHeart Failure
Interventions
DIAGNOSTIC_TEST

ECG, Echocardiography, cTnI, NT-ProBNP

All pediatric cancer survivors are evaluated with cardiological examination, ECG, transthoracic echocardiography (transesophageal echocardiography when required), NT-proBNP, cTnI, kidney function tests, liver function tests, fasting blood glucose, cholesterol panel, iron, iron binding capacity, ferritin, transferrin saturation, B12, vitamin D, folic acid, urinanalysis, hemogram and a questionnaire about living with heart failure.

Trial Locations (1)

34093

Istanbul Faculty of Medicine, Fatih

All Listed Sponsors
lead

Istanbul University

OTHER